Root Admin Guide Posted June 1, 2019 Root Admin Report Share Posted June 1, 2019 "Concurrent improvement of ocular surface conditions observed in patients treated for rosacea of their face, led to the potential implementation of intense pulsed light (IPL) for the treatment of MGD (meibomian gland dysfunction). IPL has been widely used in dermatology to treat various conditions such as rosacea, benign vascular lesions, and pigmented lesions....Patients with low meibum expressibility and tear film instability experienced greater improvement in symptoms after IPL treatment. The improvement in meibum expressibility was also associated with a decrease in tear inflammatory cytokine levels. Therefore, meibum expressibility improvement might be a good therapeutic target of IPL treatment in patients with MGD and DED, and could be an indicator of ocular surface inflammation during IPL treatment." Sci Rep. 2019; 9: 7648.Meibum Expressibility Improvement as a Therapeutic Target of Intense Pulsed Light Treatment in Meibomian Gland Dysfunction and Its Association with Tear Inflammatory Cytokines Moonjung Choi, Soo Jung Han, Yong Woo Ji, Young Joon Choi, Ikhyun Jun, Mutlaq Hamad Alotaibi, Byung Yi Ko, Eung Kweon Kim, Tae-im Kim, Sang Min Nam, and Kyoung Yul Seo Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now